Prognostic impact of nestin expression in resected large cell neuroendocrine carcinoma of the lung

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 415-420

  Ryuge, Shinichiro ^a   Sato, Yuichi ^b   Jiang, Shi Xu ^a   Wang, Guoqin ^c   Matsumoto, Toshihide ^a   Katono, Ken ^a   Inoue, Hayato ^d   Iyoda, Akira ^a   Satoh, Yukitoshi ^a   Yoshimura, Hirokuni ^a   Masuda, Noriyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

^b School of Allied Health Sciences   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Lung cancer; Prognostic marker

Indexed keywords

CISPLATIN; DOCETAXEL; ETOPOSIDE; IRINOTECAN; KI 67 ANTIGEN; NESTIN; UFT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG CARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NERVE TISSUE PROTEINS; PROGNOSIS;

EID: 84863783298     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.03.025     Document Type: Article

References (34)

1. Travis W.D., Linnoila R.I., Tsokos M.G., Hitchcock C.L., Cutler G.B., Nieman L., et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma, An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15:529-553.
2. Travis W.D., Colby T.V., Corrin B., Shimosato Y., Brambilla E. World Health Organization international histological classification of tumours: histological typing of lung and pleural tumours 1999, Springer, Washington, DC. 3rd ed.
3. Fernandez F.G., Battafarano R.J. Large-cell neuroendocrine carcinoma of the lung: an aggressive neuroendocrine lung cancer. Semin Thorac Cardiovasc Surg 2006, 18:206-210.
4. Dresler C.M., Ritter J.H., Patterson G.A., Ross E., Bailey M.S., Wick M.R., et al. Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg 1997, 63:180-185.
5. Jiang S.X., Kameya T., Shoji M., Dobashi Y., Shinada J., Yoshimura H. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol 1998, 22:526-537.
6. Asamura H., Kameya T., Matsuno Y., Noguchi M., Tada H., Ishikawa Y., et al. Neuroendocrine neoplasms of the lung: a prognostic spectrum. J Clin Oncol 2006, 24:70-76.
7. Takei H., Asamura H., Maeshima A., Suzuki K., Kondo H., Niki T., et al. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002, 124:285-292.
8. Iyoda A., Hiroshima K., Moriya Y., Takiguchi Y., Sekine Y., Shibuya K., et al. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg 2006, 82:1802-1807.
9. Rossi G., Cavazza A., Marchioni A., Longo L., Migaldi M., Sartori G., et al. Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung. J Clin Oncol 2005, 23:8774-8785.
10. Veronesi G., Morandi U., Alloisio M., Terzi A., Cardillo G., Filosso P., et al. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer 2006, 53:111-115.
11. Saji H., Tsuboi M., Matsubayashi J., Miyajima K., Shimada Y., Imai K., et al. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Anticancer Drugs 2010, 21:89-93.
12. Lendahl U., Zimmerman L.B., McKay R.D. CNS stem cells express a new class of intermediate filament protein. Cell 1990, 60:585-595.
13. Marvin M.J., Dahlstrand J., Lendahl U., McKay R.D. A rod end deletion in the intermediate filament protein nestin alters its subcellular localization in neuroepithelial cells of transgenic mice. J Cell Sci 1998, 111(Pt 14):1951-1961.
14. Sjoberg G., Jiang W.Q., Ringertz N.R., Lendahl U., Sejersen T. Colocalization of nestin and vimentin/desmin in skeletal muscle cells demonstrated by three-dimensional fluorescence digital imaging microscopy. Exp Cell Res 1994, 214:447-458.
15. Bieberich E., MacKinnon S., Silva J., Noggle S., Condie B.G. Regulation of cell death in mitotic neural progenitor cells by asymmetric distribution of prostate apoptosis response 4 (PAR-4) and simultaneous elevation of endogenous ceramide. J Cell Biol 2003, 162:469-479.
16. Sahlgren C.M., Mikhailov A., Vaittinen S., Pallari H.M., Kalimo H., Pant H.C., et al. Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol 2003, 23:5090-5106.
17. Kawamoto M., Ishiwata T., Cho K., Uchida E., Korc M., Naito Z., et al. Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. Hum Pathol 2009, 40:189-198.
18. Kleeberger W., Bova G.S., Nielsen M.E., Herawi M., Chuang A.Y., Epstein J.I., et al. Roles for the stem cell associated intermediate filament nestin in prostate cancer migration and metastasis. Cancer Res 2007, 67:9199-9206.
19. Liu C., Chen B., Zhu J., Zhang R., Yao F., Jin F., et al. Clinical implications for nestin protein expression in breast cancer. Cancer Sci 2010, 101:815-819.
20. Ryuge S., Sato Y., Wang G.Q., Matsumoto T., Jiang S.X., Katono K., et al. Prognostic significance of nestin expression in resected non-small cell lung cancer. Chest 2011, 139:862-869.
21. Sturm N., Rossi G., Lantuejoul S., Papotti M., Frachon S., Claraz C., et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002, 33:175-182.
22. Travis W.D., Branbilla E., Muller-Hermelink H.K., Harris C.C., World Health Organization, International Agency for Research on Cancer, International Association for the Study of Lung Cancer, International Academy of Pathology Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004, IARC Press, Lyon.
23. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
24. Sugawara K., Kurihara H., Negishi M., Saito N., Nakazato Y., Sasaki T., et al. Nestin as a marker for proliferative endothelium in gliomas. Lab Invest 2002, 82:345-351.
25. Paci M., Cavazza A., Annessi V., Putrino I., Ferrari G., De Franco S., et al. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study. Ann Thorac Surg 2004, 77:1163-1167.
26. Hua J., Yu H., Dong W., Yang C., Gao Z., Lei A., et al. Characterization of mesenchymal stem cells (MSCs) from human fetal lung: potential differentiation of germ cells. Tissue Cell 2009, 41:448-455.
27. Beachy P.A., Karhadkar S.S., Berman D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004, 432:324-331.
28. Frisen J., Johansson C.B., Torok C., Risling M., Lendahl U. Rapid, widespread, and longlasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J Cell Biol 1995, 131:453-464.
29. Vaittinen S., Lukka R., Sahlgren C., Hurme T., Rantanen J., Lendahl U., et al. The expression of intermediate filament protein nestin as related to vimentin and desmin in regenerating skeletal muscle. J Neuropathol Exp Neurol 2001, 60:588-597.
30. Berman D.M., Karhadkar S.S., Hallahan A.R., Pritchard J.I., Eberhart C.G., Watkins D.N., et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 2002, 297:1559-1561.
31. Karhadkar S.S., Bova G.S., Abdallah N., Dhara S., Gardner D., Maitra A., et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004, 431:707-712.
32. Watkins D.N., Berman D.M., Burkholder S.G., Wang B., Beachy P.A., Baylin S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003, 422:313-317.
33. Jones M.H., Virtanen C., Honjoh D., Miyoshi T., Satoh Y., Okumura S., et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles. Lancet 2004, 363:775-781.
34. Usuda J., Ichinose S., Ishizumi T., Ohtani K., Inoue T., Saji H., et al. Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung. Lung Cancer 2011, 72:355-359.